$2.48 Billion is the total value of Avidity Partners Management LP's 83 reported holdings in Q3 2023. The portfolio turnover from Q2 2023 to Q3 2023 was 38.7% .
| Value | Shares | ↓ Weighting | ||||||
|---|---|---|---|---|---|---|---|---|
| BSX | Buy | BOSTON SCIENTIFIC CORP | $109,074,240 | +156.7% | 2,065,800 | +162.9% | 4.39% | +196.0% |
| JAZZ | Buy | JAZZ PHARMACEUTICALS PLC | $103,228,400 | +18.5% | 797,500 | +13.5% | 4.16% | +36.6% |
| BDX | Sell | BECTON DICKINSON & CO | $74,146,404 | -29.4% | 286,800 | -27.9% | 2.99% | -18.6% |
| NBIX | Sell | NEUROCRINE BIOSCIENCES INC | $73,361,250 | +16.9% | 652,100 | -2.0% | 2.95% | +34.8% |
| MCK | Buy | MCKESSON CORP | $72,315,555 | +67.2% | 166,300 | +64.3% | 2.91% | +92.8% |
| LEGN | Buy | LEGEND BIOTECH CORPsponsored ads | $64,953,390 | +17.8% | 967,000 | +21.0% | 2.62% | +35.8% |
| THC | Sell | TENET HEALTHCARE CORP | $63,504,782 | -21.2% | 963,800 | -2.7% | 2.56% | -9.2% |
| CI | New | THE CIGNA GROUP | $59,416,739 | – | 207,700 | +100.0% | 2.39% | – |
| IDYA | Sell | IDEAYA BIOSCIENCES INC | $57,871,318 | -17.5% | 2,144,971 | -28.2% | 2.33% | -4.9% |
| UNH | New | UNITEDHEALTH GROUP INC | $56,570,118 | – | 112,200 | +100.0% | 2.28% | – |
| SRPT | Buy | SAREPTA THERAPEUTICS INC | $54,549,000 | +60.1% | 450,000 | +51.3% | 2.20% | +84.6% |
| HUM | New | HUMANA INC | $53,663,156 | – | 110,300 | +100.0% | 2.16% | – |
| ARVN | Sell | ARVINAS INC | $51,357,814 | -25.4% | 2,614,960 | -5.7% | 2.07% | -14.0% |
| ACHC | Buy | ACADIA HEALTHCARE COMPANY IN | $50,271,650 | +14.8% | 715,000 | +30.0% | 2.02% | +32.3% |
| KRTX | Sell | KARUNA THERAPEUTICS INC | $48,478,103 | -49.4% | 286,700 | -35.2% | 1.95% | -41.7% |
| REGN | Buy | REGENERON PHARMACEUTICALS | $47,731,680 | +167.9% | 58,000 | +133.9% | 1.92% | +209.0% |
| ZTS | Buy | ZOETIS INCcl a | $45,600,158 | +22.0% | 262,100 | +20.8% | 1.84% | +40.7% |
| IMVT | Sell | IMMUNOVANT INC | $45,056,884 | +13.9% | 1,173,662 | -43.7% | 1.81% | +31.4% |
| Buy | MOONLAKE IMMUNOTHERAPEUTICSclass a ord | $44,298,804 | +117.2% | 777,172 | +94.3% | 1.78% | +150.2% | |
| DHR | New | DANAHER CORPORATION | $43,814,460 | – | 176,600 | +100.0% | 1.76% | – |
| ZNTL | Sell | ZENTALIS PHARMACEUTICALS INC | $42,126,000 | -36.0% | 2,100,000 | -10.0% | 1.70% | -26.3% |
| ITCI | New | INTRA-CELLULAR THERAPIES INC | $41,729,299 | – | 801,100 | +100.0% | 1.68% | – |
| SNDX | Sell | SYNDAX PHARMACEUTICALS INC | $40,960,920 | -31.9% | 2,821,000 | -1.8% | 1.65% | -21.4% |
| LLY | Sell | ELI LILLY & CO | $40,284,750 | -35.4% | 75,000 | -43.6% | 1.62% | -25.6% |
| NTRA | Buy | NATERA INC | $39,780,750 | +88.8% | 899,000 | +107.7% | 1.60% | +117.7% |
| ARGX | Sell | ARGENX SEsponsored adr | $39,625,378 | -44.8% | 80,600 | -56.3% | 1.60% | -36.4% |
| SGRY | Sell | SURGERY PARTNERS INC | $39,136,500 | -44.1% | 1,338,000 | -14.0% | 1.58% | -35.5% |
| LNTH | Buy | LANTHEUS HLDGS INC | $38,797,632 | +88.6% | 558,400 | +127.8% | 1.56% | +117.5% |
| PCVX | Sell | VAXCYTE INC | $38,549,292 | -11.8% | 756,165 | -13.6% | 1.55% | +1.7% |
| BPMC | Buy | BLUEPRINT MEDICINES CORP | $37,745,352 | +43.9% | 751,600 | +81.1% | 1.52% | +65.9% |
| AKRO | Sell | AKERO THERAPEUTICS INC | $37,383,678 | -21.9% | 739,100 | -27.9% | 1.50% | -9.9% |
| MIRM | New | MIRUM PHARMACEUTICALS INC | $36,114,060 | – | 1,142,850 | +100.0% | 1.45% | – |
| PRVA | Buy | PRIVIA HEALTH GROUP INC | $35,537,300 | +26.0% | 1,545,100 | +43.1% | 1.43% | +45.3% |
| DXCM | New | DEXCOM INC | $35,239,410 | – | 377,700 | +100.0% | 1.42% | – |
| Sell | BIOHAVEN LTD | $33,433,254 | +5.5% | 1,285,400 | -3.0% | 1.35% | +21.6% | |
| RCKT | Buy | ROCKET PHARMACEUTICALS INC | $32,526,420 | +23.5% | 1,587,429 | +19.7% | 1.31% | +42.4% |
| Buy | AMYLYX PHARMACEUTICALS INC | $32,169,571 | +65.5% | 1,756,940 | +94.9% | 1.30% | +90.7% | |
| IMGN | Sell | IMMUNOGEN INC | $30,437,184 | -19.3% | 1,917,907 | -4.0% | 1.23% | -6.9% |
| BIIB | Sell | BIOGEN INC | $29,658,954 | -40.2% | 115,400 | -33.7% | 1.19% | -31.0% |
| Buy | CARIBOU BIOSCIENCES INC | $28,920,013 | +146.7% | 6,050,212 | +119.3% | 1.16% | +184.8% | |
| ARWR | Buy | ARROWHEAD PHARMACEUTICALS IN | $28,586,912 | -13.3% | 1,063,897 | +15.0% | 1.15% | -0.1% |
| HCA | New | HCA HEALTHCARE INC | $28,238,504 | – | 114,800 | +100.0% | 1.14% | – |
| New | NEUMORA THERAPEUTICS INC. | $25,398,000 | – | 1,800,000 | +100.0% | 1.02% | – | |
| Buy | STRUCTURE THERAPEUTICS INCsponsored ads | $25,210,000 | +1504.4% | 500,000 | +1222.8% | 1.02% | +1745.5% | |
| UHS | Sell | UNIVERSAL HLTH SVCS INCcl b | $22,882,860 | -60.8% | 182,000 | -50.8% | 0.92% | -54.8% |
| CVAC | Sell | CUREVAC N V | $21,282,963 | -52.5% | 3,116,100 | -27.5% | 0.86% | -45.2% |
| AXSM | Sell | AXSOME THERAPEUTICS INC | $20,743,352 | -47.0% | 296,800 | -45.5% | 0.84% | -39.0% |
| RARE | Sell | ULTRAGENYX PHARMACEUTICAL IN | $19,393,600 | -53.3% | 544,000 | -39.6% | 0.78% | -46.2% |
| PRTA | Sell | PROTHENA CORP PLC | $18,446,216 | -49.5% | 382,305 | -28.5% | 0.74% | -41.8% |
| RVMD | Sell | REVOLUTION MEDICINES INC | $18,191,296 | -36.7% | 657,200 | -38.9% | 0.73% | -27.0% |
| CRNX | New | CRINETICS PHARMACEUTICALS IN | $18,141,400 | – | 610,000 | +100.0% | 0.73% | – |
| IMCR | Sell | IMMUNOCORE HLDGS PLCads | $18,071,580 | -47.6% | 348,200 | -39.4% | 0.73% | -39.5% |
| Sell | ROIVANT SCIENCES LTD | $17,558,567 | +3.2% | 1,503,302 | -10.9% | 0.71% | +19.0% | |
| Buy | AN2 THERAPEUTICS INC | $17,517,552 | +213.6% | 1,089,400 | +65.8% | 0.70% | +261.5% | |
| PHAT | Sell | PHATHOM PHARMACEUTICALS INC | $16,771,401 | -39.9% | 1,617,300 | -17.0% | 0.68% | -30.8% |
| New | DIANTHUS THERAPEUTICS INC | $16,643,963 | – | 1,217,554 | +100.0% | 0.67% | – | |
| FUSN | Buy | FUSION PHARMACEUTICALS INC | $15,032,810 | -43.5% | 5,781,850 | +1.4% | 0.60% | -34.9% |
| CERE | Buy | CEREVEL THERAPEUTICS HLDNG I | $14,036,690 | -11.9% | 643,000 | +28.3% | 0.56% | +1.6% |
| VRNA | Sell | VERONA PHARMA PLCsponsored ads | $13,533,890 | -32.9% | 830,300 | -13.0% | 0.54% | -22.7% |
| Sell | VENTYX BIOSCIENCES INC | $12,325,677 | -45.7% | 354,900 | -48.8% | 0.50% | -37.5% | |
| NTLA | Sell | INTELLIA THERAPEUTICS INC | $11,987,142 | -25.7% | 379,100 | -4.2% | 0.48% | -14.4% |
| TVTX | New | TRAVERE THERAPEUTICS INC | $11,827,620 | – | 1,323,000 | +100.0% | 0.48% | – |
| SDGR | Buy | SCHRODINGER INC | $11,279,730 | -17.8% | 399,000 | +45.1% | 0.45% | -5.2% |
| KPTI | Sell | KARYOPHARM THERAPEUTICS INC | $11,120,084 | -25.8% | 8,298,570 | -0.9% | 0.45% | -14.3% |
| New | RAYZEBIO INC | $11,100,000 | – | 500,000 | +100.0% | 0.45% | – | |
| XENE | Sell | XENON PHARMACEUTICALS INC | $10,979,024 | -40.8% | 321,400 | -33.2% | 0.44% | -31.7% |
| PACB | Sell | PACIFIC BIOSCIENCES CALIF IN | $8,636,355 | -85.0% | 1,034,294 | -76.2% | 0.35% | -82.7% |
| ACIU | Buy | AC IMMUNE SA | $8,463,930 | -1.3% | 2,969,800 | +2.3% | 0.34% | +13.7% |
| COLL | Sell | COLLEGIUM PHARMACEUTICAL INC | $7,826,970 | +2.9% | 350,200 | -1.1% | 0.32% | +18.4% |
| ALPN | Sell | ALPINE IMMUNE SCIENCES INC | $7,525,856 | -30.8% | 657,280 | -37.9% | 0.30% | -20.3% |
| KZR | Sell | KEZAR LIFE SCIENCES INC | $7,153,209 | -52.0% | 6,011,100 | -1.1% | 0.29% | -44.6% |
| Buy | SYROS PHARMACEUTICALS INC | $6,245,511 | +35.4% | 1,581,142 | +8.0% | 0.25% | +56.5% | |
| GRTS | Sell | GRITSTONE BIO INC | $4,702,136 | -12.8% | 2,733,800 | -1.1% | 0.19% | +0.5% |
| ATEC | Sell | ALPHATEC HLDGS INC | $4,012,918 | -43.2% | 309,400 | -21.3% | 0.16% | -34.4% |
| NSTG | Sell | NANOSTRING TECHNOLOGIES INC | $3,954,452 | -63.8% | 2,299,100 | -14.9% | 0.16% | -58.4% |
| VERV | Sell | VERVE THERAPEUTICS INC | $3,783,529 | -77.0% | 285,334 | -67.5% | 0.15% | -73.6% |
| CMPX | Sell | COMPASS THERAPEUTICS INC | $3,151,212 | -38.8% | 1,599,600 | -1.3% | 0.13% | -29.4% |
| ALT | Sell | ALTIMMUNE INC | $3,015,740 | -27.2% | 1,159,900 | -1.2% | 0.12% | -16.6% |
| SCYX | Sell | SCYNEXIS INC | $3,008,332 | -41.3% | 1,319,444 | -24.1% | 0.12% | -32.4% |
| HYPERFINE INC | $2,435,765 | -4.7% | 1,188,178 | 0.0% | 0.10% | +10.1% | ||
| IPSC | Sell | CENTURY THERAPEUTICS INC | $2,197,000 | -37.4% | 1,098,500 | -1.1% | 0.09% | -28.5% |
| CMAX | CAREMAX INC | $1,348,320 | -31.8% | 636,000 | 0.0% | 0.05% | -21.7% | |
| NUVBWS | Sell | NUVATION BIO INC*w exp 07/07/202 | $8,954 | -40.2% | 89,543 | -1.1% | 0.00% | -100.0% |
| Exit | ARTERIS INC | $0 | – | -75,500 | -100.0% | -0.02% | – | |
| Exit | EXSCIENTIA PLCads | $0 | – | -127,600 | -100.0% | -0.03% | – | |
| BHC | Exit | BAUSCH HEALTH COS INC | $0 | – | -215,100 | -100.0% | -0.06% | – |
| SLP | Exit | SIMULATIONS PLUS INC | $0 | – | -45,900 | -100.0% | -0.07% | – |
| DNLI | Exit | DENALI THERAPEUTICS INC | $0 | – | -282,752 | -100.0% | -0.29% | – |
| ETNB | Exit | 89BIO INC | $0 | – | -526,376 | -100.0% | -0.35% | – |
| NARI | Exit | INARI MED INC | $0 | – | -175,000 | -100.0% | -0.36% | – |
| MRSN | Exit | MERSANA THERAPEUTICS INC | $0 | – | -3,790,000 | -100.0% | -0.44% | – |
| Exit | MINERALYS THERAPEUTICS INC | $0 | – | -766,700 | -100.0% | -0.46% | – | |
| Exit | 2SEVENTY BIO INC | $0 | – | -1,342,000 | -100.0% | -0.47% | – | |
| PNT | Exit | POINT BIOPHARMA GLOBAL INC | $0 | – | -1,671,800 | -100.0% | -0.53% | – |
| Exit | ACELYRIN INC | $0 | – | -750,000 | -100.0% | -0.55% | – | |
| PLRX | Exit | PLIANT THERAPEUTICS INC | $0 | – | -916,600 | -100.0% | -0.58% | – |
| AXNX | Exit | AXONICS INC | $0 | – | -379,700 | -100.0% | -0.67% | – |
| EDIT | Exit | EDITAS MEDICINE INC | $0 | – | -3,000,000 | -100.0% | -0.86% | – |
| BAX | Exit | BAXTER INTL INC | $0 | – | -604,700 | -100.0% | -0.96% | – |
| VIR | Exit | VIR BIOTECHNOLOGY INC | $0 | – | -1,425,000 | -100.0% | -1.22% | – |
| PFE | Exit | PFIZER INC | $0 | – | -1,117,467 | -100.0% | -1.43% | – |
| APLS | Exit | APELLIS PHARMACEUTICALS INC | $0 | – | -468,700 | -100.0% | -1.49% | – |
| ABC | Exit | AMERISOURCEBERGEN CORP | $0 | – | -300,000 | -100.0% | -2.02% | – |
| BIO | Exit | BIO RAD LABS INCcl a | $0 | – | -152,600 | -100.0% | -2.02% | – |
| ABBV | Exit | ABBVIE INC | $0 | – | -518,400 | -100.0% | -2.44% | – |
| Exit | GE HEALTHCARE TECHNOLOGIES I | $0 | – | -1,045,400 | -100.0% | -2.97% | – |
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2023-11-14
Top long-term holdings
| Name | Quarters owned | Latest quarter owned | Max weighting |
|---|---|---|---|
| NEUROCRINE BIOSCIENCES INC | 15 | Q3 2023 | 4.6% |
| ARVINAS INC | 14 | Q3 2023 | 4.9% |
| ZENTALIS PHARMACEUTICALS INC | 14 | Q3 2023 | 4.8% |
| SYNDAX PHARMACEUTICALS INC | 14 | Q3 2023 | 3.2% |
| IDEAYA BIOSCIENCES INC | 13 | Q3 2023 | 2.5% |
| NATERA INC | 13 | Q3 2023 | 1.9% |
| ALPINE IMMUNE SCIENCES INC | 13 | Q3 2023 | 0.5% |
| ABBVIE INC | 12 | Q2 2023 | 9.7% |
| HORIZON THERAPEUTICS PUB LTD | 12 | Q3 2022 | 3.4% |
| AVANTOR INC | 11 | Q1 2023 | 6.0% |
View Avidity Partners Management LP's complete holdings history.
Latest significant ownerships (13-D/G)
| Filed | Shares | Percentage | |
|---|---|---|---|
| Adicet Bio, Inc.Sold out | February 14, 2023 | 0 | 0.0% |
| ALPINE IMMUNE SCIENCES, INC. | February 14, 2023 | 1,888,887 | 4.0% |
| ESSA Pharma Inc. | February 14, 2023 | 1,855,400 | 4.2% |
| Gritstone bio, Inc. | February 14, 2023 | 2,859,971 | 3.3% |
| IVERIC bio, Inc. | February 14, 2023 | 838,407 | 0.6% |
| ONCOSEC MEDICAL IncSold out | February 14, 2023 | 0 | 0.0% |
| PhaseBio Pharmaceuticals Inc | February 14, 2023 | 2,040,000 | 4.1% |
| Phathom Pharmaceuticals, Inc. | February 14, 2023 | 1,900,000 | 4.6% |
| Viridian Therapeutics, Inc.Sold out | February 14, 2023 | 0 | 0.0% |
| Anika Therapeutics, Inc.Sold out | February 14, 2022 | 0 | 0.0% |
View Avidity Partners Management LP's complete significant-ownership history.
Latest filings
| Type | Filed |
|---|---|
| SC 13G | 2024-04-09 |
| SC 13G | 2024-03-27 |
| 13F-HR | 2024-02-14 |
| SC 13G/A | 2024-02-14 |
| SC 13G/A | 2024-02-14 |
| SC 13G/A | 2024-02-14 |
| SC 13G/A | 2024-02-14 |
| SC 13G/A | 2024-02-13 |
| SC 13G/A | 2024-02-13 |
| SC 13G/A | 2024-02-13 |
View Avidity Partners Management LP's complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.